Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
SRPT Sarepta Therapeutics
- 118.970
- -0.500-0.42%
Close Dec 20 16:00 ET
- 119.300
- +0.330+0.28%
Post 20:01 ET
11.36BMarket Cap77.25P/E (TTM)
121.000High118.560Low1.95MVolume119.590Open119.470Pre Close232.72MTurnover2.14%Turnover RatioLossP/E (Static)95.52MShares173.25052wk High9.31P/B10.84BFloat Cap91.34452wk Low--Dividend TTM91.15MShs Float181.830Historical High--Div YieldTTM2.04%Amplitude2.598Historical Low119.161Avg Price1Lot Size
About Sarepta Therapeutics Company
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Company Profile
SymbolSRPT
Company NameSarepta Therapeutics
Listing DateJun 4, 1997
Issue Price9.00
Founded1980
CEOMr. Christopher Garabedian
MarketNASDAQ
Employees1314
Fiscal Year Ends12-31
Address215 First Street,Suite 415
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-274-4000
Websitehttp://www.sarepta.com
Company Executives
- Name
- Position
- Salary
- Douglas S. Ingram,Esq.
- Director, President and Chief Executive Officer
- 1.66M
- Louise Rodino-Klapac
- Executive Vice President, Head of R&D and Chief Scientific Officer
- 3.72M
- Bilal Arif
- Executive Vice President and Chief Technical Operations Officer
- 3.52M
- Ian Michael Estepan
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 3.71M
- Dallan Murray
- Executive Vice President and Chief Customer Officer
- --
- Cristin Rothfuss
- Executive Vice President and General Counsel
- --
- Deirdre P. Connelly
- Director
- --
- Michael Chambers
- Independent Director
- 533.99K
- Dr. Kathryn Jean Boor, PhD
- Independent Director
- 543.58K
- Dr. Hans Wigzell, M.D.,PhD
- Independent Director
- 546.99K
- Dr. Claude Nicaise,M.D.
- Independent Director
- 553.34K
- Richard J. Barry
- Independent Director
- 563.65K
- Dr. Stephen L. Mayo, PhD
- Independent Director
- 546.49K
- Dr. M. Kathleen Behrens Wilsey, PhD
- Chairwoman of the Board
- 594.99K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.